Previous close | 0.0570 |
Open | 0.0550 |
Bid | 0.0560 x 19973700 |
Ask | 0.0610 x 27494300 |
Day's range | 0.0540 - 0.0560 |
52-week range | 0.0410 - 0.0940 |
Volume | |
Avg. volume | 126,490 |
Market cap | 17.16M |
Beta (5Y monthly) | 0.26 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
It is hard to get excited after looking at Regeneus' (ASX:RGS) recent performance, when its stock has declined 8.8...
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce a research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute at Royal North Shore Hospital, Australia.